Friday, 25 September 2026European Markets

COVIVIO And NEXTENSA Have A High Dividend Yield And Return On Equity In The REIT—Diversified Industry.

Loading stream...

(vianews) - covivio (cov.pa) is among this list of stock assets with the highest dividend rate and return on equity on the reit—diversified industry.

financial asset price forward dividend yield return on equity
covivio (cov.pa) €48.78 7.89% 8.28%
nextensa (nexta.br) €48.55 5.53% 8.68%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. covivio (cov.pa)

7.89% forward dividend yield and 8.28% return on equity

thanks to its partnering history, its real estate expertise and its european culture, covivio is inventing today's user experience and designing tomorrow's city. a preferred real estate player at the european level, covivio is close to its end users, capturing their aspirations, combining work, travel, living, and co-inventing vibrant spaces. a benchmark in the european real estate market with €26 bn in assets, covivio offers support to companies, hotel brands and territories in their pursuit for attractiveness, transformation, and responsible performance. build sustainable relationships and well-being, is the covivio's purpose who expresses its role as a responsible real estate operator to all its stakeholders: customers, shareholders and financial partners, internal teams, local authorities but also to future generations and the planet. furthermore, its living, dynamic approach opens up exciting project and career prospects for its teams. covivio's shares are listed in the euronext paris a compartment (fr0000064578 - cov) and on the mta market (mercato telematico azionario) of the milan stock exchange, are admitted to trading on the srd, and are included in the composition of the msci, sbf 120, euronext ieif “siic france” and cac mid100 indices, in the “epra” and “gpr 250” benchmark european real estate indices, epra bprs gold awards (financial + extra-financial), cdp (a-), 5 star gresb and in the esg ftse4 good, cac sbt 1.5°c, djsi world & europe, euronext vigeo (world 120, eurozone 120, europe 120 and france 20), euronext cdp environment france ew, iss esg, ethibel and gaïa ethical indices and also holds the following awards and ratings: cdp (b), gresb (5-star, 100% public disclosure), vigeo-eiris (a1+), iss-esg (b-) and msci (aaa).

earnings per share

as for profitability, covivio has a trailing twelve months eps of €6.57.

pe ratio

covivio has a trailing twelve months price to earnings ratio of 7.42. meaning, the purchaser of the share is investing €7.42 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.28%.

revenue growth

year-on-year quarterly revenue growth grew by 7.3%, now sitting on 1.07b for the twelve trailing months.

dividend yield

as stated by morningstar, inc., the next dividend payment is on apr 24, 2023, the estimated forward annual dividend rate is 3.75 and the estimated forward annual dividend yield is 7.89%.

yearly top and bottom value

covivio's stock is valued at €48.78 at 12:40 est, way below its 52-week high of €69.35 and above its 52-week low of €44.40.

more news about covivio.

2. nextensa (nexta.br)

5.53% forward dividend yield and 8.68% return on equity

nextensa sa is a mixed real estate investor and developer. the company's investment portfolio is divided between the grand duchy of luxembourg (41%), belgium (44%) and austria (15%); its total value as of 31/12/2022 was approximately € 1.28 billion. as a developer, nextensa is primarily active in shaping large urban developments. at tour & taxis (development of over 350,000 sqm) in brussels, nextensa is building a mixed real estate portfolio consisting of a revaluation of iconic buildings and new constructions. in luxembourg (cloche d'or), it is working in partnership on a major urban extension of more than 400,000 sqm consisting of offices, retail and residential buildings. the company is listed on euronext brussels and has a market capitalization of €519.1 million (value 31/12/2022).

earnings per share

as for profitability, nextensa has a trailing twelve months eps of €7.18.

pe ratio

nextensa has a trailing twelve months price to earnings ratio of 6.76. meaning, the purchaser of the share is investing €6.76 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.68%.

revenue growth

year-on-year quarterly revenue growth grew by 58.2%, now sitting on 164.92m for the twelve trailing months.

more news about nextensa.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com